Stockreport

Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neuro [Read more]